Part Three in a Three Part Series

Part One, Tuesday Sept. 21: No approval, no protection

Part Two, Wednesday Sept. 22: Big Pharma corruption

By Alison Despathy

For many justified and legitimate reasons, not all Vermonters have raced out to get vaccinated. They struggle with this personal, private and many-layered decision. 

So many factors influence this personal choice. Medical history and health concerns. The impact and role of personal health responsibility. Religious and/or philosophical convictions. Concern about synthetic biology. A brand new vaccine technology being deployed on a massive scale.

And there is this: the current CDC Vaccine Adverse Event Reporting System (VAERS) shows the absolute, hands-down highest numbers ever reported for adverse events, including deaths, related to a vaccine. As of August 20, the number of adverse events reported to VAERS is 623,341 and the number of deaths reported is 13,627.

Has The U.S. Dept. of Health and Human Services actually had enough time to really work through all of the VAERS reports? Has it determined what true risks come with the new technology found within these experimental injections? We are currently trying to determine the true effects and impacts of these ‘vaccines.’ This takes time. It cannot be rushed.

Self preservation is innately embedded in humans. It is an instinctual quality that is arguably one of the major reasons we are still on this planet. All of these questions are important. We need answers. Individuals’ personal and private decisions regarding their health must be respected. No one size fits all – never has been, never will be. And there are no clear answers at this point. There is a tremendous amount of current research and data collection and analysis but it is all in the early stages. We simply do not know the safety and efficacy of these ‘vaccines’. 

Some of the most recent research and raw data from around the world, including Israel, one of the early forerunners in high population vaccine rates, is shedding light on both the high level of transmissibility and breakthrough Covid infections among the vaccinated. There are risks taken in either regard. A clear bottom line is that a person should be able to choose what happens to their body. This is intimately tied to self preservation and self determination. There have been horrible and hideous instances throughout history that have taught us this valuable lesson about the individual’s right of body autonomy.
Health choice, body autonomy, informed consent, health privacy and medical freedom are critical rights of the individual and they impact everything that stems from individuals including healthy communities, society, culture, local economies and government.

We are composed of I’s – unique, individual I’s. What I believe may be different than what you believe. And that is OK.

What repeatedly gets missed by the mainstream media and social media is that there are treatment and prevention options These prescriptions and supplements hold actual safety records for decades. They show as highly effective. Doctors in clinical practice as well as research and clinical trials trying to share this information have been censored, smeared or deplatformed because their information interferes with the vaccine campaign and narrative. 

Yes, there are options available besides the experimental ‘vaccine’. American Frontline Doctors and the doctors and scientists who have signed on to the Great Barrington Declaration are two of the larger groups committed to offering guidance, options and the other side of the ‘vaccine’ narrative story. They are worth looking into in order to attempt to grasp another perspective.

Right now so much is fear-driven and impulsive. Other options for treatment and prevention of Covid have much higher levels of safety and effectiveness than the ‘vaccine.’ Maybe this will offer a level of comfort and a chance to take a breath and consider that there is actually another path being presented and it is worth research and consideration. Is a vaccine, an experimental, synthetic genetic material ‘vaccine’, with a rushed approval process, truly our answer and our only way through? As is evident both the scientific community and humanity feel differently about this solution. Remaining open to respectful conversations with each other about these differences is vital for the future of humanity and to navigate the best path forward. 

In addition to the historical and current factors that influence Covid ‘vaccine’ hesitancy, there are also a tremendous amount of both documented and preliminary research findings and evidence accumulating in the scientific community regarding questions and concerns related to both the safety and efficacy of these experimental injections. The majority of the research in this area relates to questions involving the cytotoxicity of the spike protein itself and its potential involvement in mitochondrial damage, blood clots and inflammatory pathways. Also there are questions regarding the ‘vaccine’s’ potential role in driving “immune escape” variants, the question of antibody dependent enhancement, risks of autoimmune conditions due to vaccines, the narrow design focus of the clinical trial including the emphasis on relative risk reduction versus absolute risk reduction and the question regarding the unknown, long term effects of these injections.

These valid observations and critical questions are a major player for many in the vaccine hesitancy and concern conversation. More time is required for this information to be accurately assessed and understood. I have included multiple sources for further insight and research into the safety and efficacy questions regarding these current injections. Please see the sources listed below, under the specific topics of concern mentioned.

There is a tremendous amount of raw data relating to the issue surrounding vaccinated individuals both contracting and transmitting Covid. This is not rare, it is quite common and this situation heavily focuses the question of effectiveness and what these ‘vaccines’ are actual offering in terms of immunity or protection. There is not clarity or certainty in any of these areas of the science. These are some of the many fundamental concerns of the current experimental injections developed for covid. This again is why the precautionary principle and health choice and body autonomy become critical in guiding decisions regarding any policy related to ‘vaccines’ at this time. 

I felt that it was important to voice some of these concerns to try and convey the depth of hesitation that many are struggling with and why. This is not “antivaxxer sentiment,” this is highly concerned, informed, well-researched, legitimate  and necessary questioning regarding the safety, effectiveness and future of covid ‘vaccines’ and the search for the best path forward.

Especially since we are dealing with new vaccine technology involving synthetic genetic material, a rushed FDA approval process, a serial felon-Pfizer, and a questionable and disturbing FDA approval of a liability-free and currently unavailable Covid ‘vaccine’ – Comirnaty. 

Self determination and self preservation both exist at the core of freedom and survival and should be respected at all times, especially given the legitimate, fundamental questions raised here. We do not have all the answers at this point. This is very difficult and scary for some people to hear and acknowledge but we must face the truth and be cautious in our approach and allow more time for the safety and effectiveness of these experimental ‘vaccines’ to be assessed properly. 

Taking the precautionary principle in our decisions and respecting health choice, versus demanding and placing undeserved faith in a potentially false solution that promises protection and security and comes with unknown results and risks, is justified in our current situation.

The philosopher William James stated, “Our science is a drop, our ignorance a sea.” There is so much we do not understand and know in the world of science and covid, acknowledging this fact is crucial to prevent unnecessary destruction and damage by acting in haste and impulsivity regarding experimental injections and health policy. People are landing in different places with regards to perspective, safety and questions surrounding the current data and research. 

When we stand for health choice and medical freedom we are working towards the preservation and fortification of human rights and civil liberties intrinsic in each of us, as unique individuals, traveling on this journey together. Our right to choose and our right to refuse must be respected at all times in order to secure the future of health choice, body autonomy, medical freedom and quite possibly humanity. 

The author is a mother, clinical nutritionist, and teacher living in Danville, VT.  She has had a clinical nutrition practice in St. Johnsbury and has taught nutrition for over twenty years. 

SOURCES FOR PARTS 1-3 
H.R.5546 – 99th Congress (1985-1986): National Childhood Vaccine Injury Act of 1986 | Congress.gov | Library of Congress
The powerful technology behind the Pfizer and Moderna vaccines | PBS NewsHour
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals – Full Text View – ClinicalTrials.gov
Fifty Years Later: The Significance of the Nuremberg Code | NEJM
Tough on Crime? Pfizer and the CIHR – PubMed (nih.gov)
Pfizer pleads guilty, but drug sales continue to soar (nih.gov)
The pharmaceutical industry and the German National Socialist Regime: I.G. Farben and pharmacological research – PubMed (nih.gov)
Pfizer settles largest ever fraud suit for off-label promotion | Nature Biotechnology
Nigeria files criminal charges against Pfizer (nih.gov)
Pfizer to pay $2.3 billion, agrees to criminal plea | Reuters
Pfizer settles foreign bribery case with U.S. government | Reuters
Pfizer | Company History, Products & Lawsuits, COVID-19 Vaccine (drugwatch.com)
Pfizer – History of Pfizer, Products & Legal Claims (drugdangers.com)
2 Things Mainstream Media Didn’t Tell You About FDA’s Approval of Pfizer Vaccine • Children’s Health Defense (childrenshealthdefense.org)
One-Third Of New Drugs Had Safety Problems After Approval : Shots – Health News : NPR
Final-Pfizer LOA to issue with BLA approval 08.23.21-v2 – Google Docs
Key+points+to+consider+FDA+letters+and+press+release – Google Docs
Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs by Donald W. Light, Joel Lexchin, Jonathan J. Darrow :: SSRN
New Prescription Drugs: A Major Health Risk With Few Offsetting Advantages | Edmond J. Safra Center for Ethics (harvard.edu)
The false claim that the fully-approved Pfizer vaccine lacks liability protection – The Washington Post
Necessity of COVID-19 vaccination in previously infected individuals | medRxiv
COVID Vaccine Data (openvaers.com)
VAERS – Report an Adverse Event (hhs.gov)
Federal Register :: Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19
COVID19 PCR Tests are Scientifically Meaningless – OffGuardian (off-guardian.org)
A grim warning from Israel: Vaccination blunts, but does not defeat Delta | Science | AAAS
Having SARS-CoV-2 once confers much greater immunity than a vaccine—but vaccination remains vital | Science | AAAS
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections | medRxiv
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals – Full Text View – ClinicalTrials.gov
For Big Pharma, the revolving door keeps spinning | TheHill
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells – PubMed (nih.gov)
America’s Frontline Doctors (americasfrontlinedoctors.org)
Great Barrington Declaration (gbdeclaration.org)

SPIKE PROTEIN and CYTOTOXICITY
How the coronavirus infects cells — and why Delta is so dangerous (nature.com)
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier – ScienceDirect
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech) | Journal of Pharmaceutical Policy and Practice | Full Text (biomedcentral.com)
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 | Journal of Hematology & Oncology | Full Text (biomedcentral.com)
Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity (plos.org)
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 | medRxiv
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients | Clinical Infectious Diseases | Oxford Academic (oup.com)
“Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines | Research Square
SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues toneurodegeneration – ScienceDirect
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 | Circulation Research (ahajournals.org)
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines (nih.gov)
An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner | Leukemia (nature.com)IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6 (nih.gov)
SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells | Journal of Virology (asm.org)

LIPID NANOTECHNOLOGY IN COVID VACCINES
0vwcmj.pdf (catbox.moe)
Understanding the nanotechnology in COVID-19 vaccines | CAS

POTENTIAL FOR VACCINE-INDUCED VARIANTS
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern (science.org)
Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens (plos.org)
Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains | Scientific Reports (nature.com)

ANTIBODY DEPENDENT ENHANCEMENT CONCERNS
Caution raised over SARS vaccine | Nature
A perspective on potential antibody-dependent enhancement of SARS-CoV-2 | Nature
Antibody-dependent enhancement of coronavirus – PubMed (nih.gov)
At the Intersection Between SARS-CoV-2, Macrophages and the Adaptive Immune Response: A Key Role for Antibody-Dependent Pathogenesis But Not Enhancement of Infection in COVID-19 | bioRxiv

POTENTIAL AUTOIMMUNE RISKS DUE TO VACCINES
SARS vaccine linked to liver damage in ferret study | CIDRAP (umn.edu)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets – PubMed (nih.gov)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus (plos.org)
Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets | Journal of Virology (asm.org)Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity – ScienceDirect
QUESTIONS ON VACCINE EFFICACY- RELATIVE RISK REDUCTION vs ABSOLUTE RISK REDUCTION
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room – The Lancet Microbe
SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity – PubMed (nih.gov)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization | Nature

CONSIDERATION FOR ALTERNATIVE TREATMENT STRATEGY
Emergency Use Authorization | FDA – If there are existing treatments available then EUA is not possible.
Ivermectin for Prevention and Treatment of COVID-19 Infectio… : American Journal of Therapeutics (lww.com)
Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial | medRxiv
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19 – Elalfy – 2021 – Journal of Medical Virology – Wiley Online Library
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness – PubMed (nih.gov)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro – ScienceDirect
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug (nih.gov)
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach (nih.gov)
Nota-Journal-of-Biomedical-Research-Safety-and-Efficacy-Iota-Carrageenan-and-Ivermectin.pdf (buongiornosuedtirol.it)
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness – International Journal of Infectious Diseases (ijidonline.com)
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial – PubMed (nih.gov)Frontiers | Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 | Pharmacology (frontiersin.org)

THE CASE FOR NATURAL IMMUNITY vs VACCINE IMMUNITY
Necessity of COVID-19 vaccination in previously infected individuals | medRxiv
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans | Nature
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells | medRxiv
Quantifying the risk of SARS‐CoV‐2 reinfection over time (nih.gov)
VAERS
(PDF) Analysis of COVID-19 vaccine death reports from the Vaccine Adverse Events Reporting System (VAERS) Database Interim: Results and Analysis (researchgate.net)